Leiden University Medical Center at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Leiden University Medical Center brings 3 presentations to ESGCT 2026 in Hamburg. Its work covers gene therapy for Duchenne muscular dystrophy and inherited immune deficiency, including local CRISPR editing in muscle and stem cells made from induced pluripotent cells to test RAG1 deficiency strategies. It also offers a three-dimensional culture platform supporting human B cell development.
| Organization | ESGCT 2026 Attendance |
|---|---|
Leiden University Medical Center Leiden, Netherlands | |
Poster Wed Oct 28 1:30pm–3:30pm Translational development of in vivo local CRISPR-Cas gene editing in Duchenne muscular dystrophy Poster Wed Oct 28 1:30pm–3:30pm iPSC-derived Hematopoietic Stem Cells can be used to test Gene Therapy Strategies for RAG1 Hypomorphic Immune Deficiency Rare and inherited diseaseCell therapies and CAR-T Poster Thu Oct 29 2:00pm–4:00pm ABO: a 3D stroma-supported culture platform enabling full human B-lymphopoiesis for disease modelling and gene therapy development |
Instantly find 20 buyers from Leiden University Medical Center
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction